Search results
SixPeaks, a new obesity biotech, starts up with an option to sell to AstraZeneca
BioPharma Dive via Yahoo Finance· 6 days agoOver that time, AstraZeneca has an exclusive chance to buy SixPeaks at an agreed-upon price once...
Is Vaginal Estrogen Safe in Breast Cancer Survivors?
Medscape· 6 days agoVaginal estrogen therapy appears to be safe after early breast cancer in patients with HR-negative tumors and those with HR-positive tumors concurrently...
ASCO: J&J's radioligand spurs responses, but 4 deaths mar early results
FierceBiotech· 4 days agoJohnson & Johnson’s radiopharmaceutical spurred “profound and durable” responses, however, four...
Perseus Therapeutics Announces Development of TSLP Antibody for Prevention of Hair Loss in Cancer...
WKBN 27 Youngstown· 6 days agoPerseus Therapeutics, a pioneering biopharmaceutical company based in New York City, is proud to announce the development of a novel thymic stromal lymphopoietin (TSLP) antibody aimed at preventing ...
Exercise Improves Sexual Health in Metastatic Breast Cancer
Medscape· 7 days agoExercise can help improve sexual health in women with metastatic breast cancer and should be a key...
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a...
CNBC· 5 days agoIt's called targeted radiopharmaceutical therapy. RBC Capital Markets sees a $25 billion market...
The AI effect: How a hot computing tool is tying ‘bio’ and ‘tech’ closer than ever - San Francisco...
The Business Journals· 5 days agoJames Fraser had his doubts. After all, decades of scientific rigor say that discovering drugs —...
A corner of the cancer therapy market is heating up—Here are the names investors need to know
CNBC· 5 days agoThere's been a lot of attention lately on a corner of the oncology market called radiopharmaceuticals. The therapy seeks to destroy cancer cells by binding a radioactive particle to a targeted ...
BostonGene Immune Profiling Platform Shows Promise in Predicting Cancer Immunotherapy Benefit
GenomeWeb News· 4 days agoBostonGene wants to further validate a blood-based, machine learning-powered immune profiling platform that has shown potential in classifying cancer patients' immune phenotypes and monitoring ...